Literature DB >> 31876042

The evolution of sentinel node biopsy for breast cancer: Personal experience.

Armando E Giuliano1.   

Abstract

Sentinel node biopsy has dramatically altered the treatment of breast cancer worldwide. The author's investigation into its use in breast cancer began nearly 30 years ago and evolved from simply identifying a node predictive of the axillary status to being a therapeutic procedure eliminating axillary dissection for selected node-negative and some node-positive women. This paper summarizes a personal experience with the evolution of this technique.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; sentinel node

Mesh:

Year:  2019        PMID: 31876042     DOI: 10.1111/tbj.13729

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  4 in total

1.  Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node.

Authors:  Ning Liao; Cheukfai Li; Li Cao; Yanhua Chen; Chongyang Ren; Xiaoqing Chen; Hsiaopei Mok; Lingzhu Wen; Kai Li; Yulei Wang; Yuchen Zhang; Yingzi Li; Jiaoyi Lv; Fangrong Cao; Yuting Luo; Hongrui Li; Wendy Wu; Charles M Balch; Armando E Giuliano
Journal:  Breast Cancer       Date:  2022-09-21       Impact factor: 3.307

2.  Breast-conserving surgery and sentinel lymph node biopsy for breast cancer and their correlation with the expression of polyligand proteoglycan-1.

Authors:  Fu-Ming Li; Dan-Ying Xu; Qi Xu; Yan Yuan
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

Review 3.  Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®).

Authors:  Stanley P Leong
Journal:  Clin Exp Metastasis       Date:  2021-12-28       Impact factor: 5.150

Review 4.  The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis.

Authors:  Stanley P Leong; Alexander Pissas; Muriel Scarato; Francoise Gallon; Marie Helene Pissas; Miguel Amore; Max Wu; Mark B Faries; Amanda W Lund
Journal:  Clin Exp Metastasis       Date:  2021-10-15       Impact factor: 5.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.